Year archive

China Resources Pharmaceutical Group Limited — 2026 filings

All 53 regulatory filings released by China Resources Pharmaceutical Group Limited (3320) in 2026, sourced directly from the official regulator.

53 Filings

2026 Period

2026 filings (53)

Filing	Released	Lang
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 (UPDATED) Notice of Dividend Amount	2026-05-19	English
Proxy Form AGM Information	2026-05-19	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2026-05-19	English
PROPOSALS FOR GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES, RE-ELECTION OF RETIRING DIRECTORS, APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING AGM Information	2026-05-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 Regulatory Filings	2026-05-04	English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR PHARMACEUTICAL COMMERCIAL FOR THE THREE MONTHS ENDED 31 MARCH 2026 IN RELATION TO ISSUANCE OF MEDIUM TERM NOTES IN THE PRC Interim / Quarterly Report	2026-04-30	English
2025 Sustainability Report Environmental & Social Information	2026-04-28	English
2025 Annual Report Regulatory Filings	2026-04-28	English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR BOYA BIO-PHARMACEUTICAL FOR THE THREE MONTHS ENDED 31 MARCH 2026 Earnings Release Q1 2026	2026-04-24	English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF KPC FOR THE THREE MONTHS ENDED 31 MARCH 2026 Earnings Release Q1 2026	2026-04-24	English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR SANJIU FOR THE THREE MONTHS ENDED 31 MARCH 2026 Earnings Release Q1 2026	2026-04-24	English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF TASLY PHARMACEUTICAL FOR THE THREE MONTHS ENDED 31 MARCH 2026 Earnings Release Q1 2026	2026-04-24	English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR JIANGZHONG FOR THE THREE MONTHS ENDED 31 MARCH 2026 Earnings Release Q1 2026	2026-04-24	English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR DOUBLE-CRANE FOR THE THREE MONTHS ENDED 31 MARCH 2026 Earnings Release Q1 2026	2026-04-24	English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF DONG-E-E-JIAO FOR THE THREE MONTHS ENDED 31 MARCH 2026 Earnings Release Q1 2026	2026-04-24	English
INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE FIRST TRANCHE OF 2026 CORPORATE BONDS IN THE PRC Capital/Financing Update	2026-04-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-01	English
INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE FIRST TRANCHE OF 2026 CORPORATE BONDS IN THE PRC Capital/Financing Update	2026-03-27	English
INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE FIRST TRANCHE OF 2026 CORPORATE BONDS IN THE PRC Capital/Financing Update	2026-03-26	English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 Notice of Dividend Amount	2026-03-24	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 Earnings Release FY 2025	2026-03-24	English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR SANJIU FOR THE YEAR ENDED 31 DECEMBER 2025 Report Publication Announcement	2026-03-20	English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR BOYA BIO-PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2025 Report Publication Announcement	2026-03-20	English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF DONG-E-E-JIAO FOR THE YEAR ENDED 31 DECEMBER 2025 Regulatory Filings	2026-03-19	English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF KPC FOR THE YEAR ENDED 31 DECEMBER 2025 Report Publication Announcement	2026-03-19	English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR DOUBLE-CRANE FOR THE YEAR ENDED 31 DECEMBER 2025 Report Publication Announcement	2026-03-19	English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF TASLY PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2025 Regulatory Filings	2026-03-19	English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR JIANGZHONG FOR THE YEAR ENDED 31 DECEMBER 2025 Report Publication Announcement	2026-03-19	English
INSIDE INFORMATION POTENTIAL DISPOSAL OF TIANMAI BIOTECHNOLOGY M&A Activity	2026-03-16	English
DATE OF BOARD MEETING Report Publication Announcement	2026-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 Share Issue/Capital Change	2026-03-02	English
INSIDE INFORMATION INVESTMENT IN AND CONSTRUCTION OF THE HEALTH CONSUMER PRODUCTS INDUSTRIAL PARK Capital/Financing Update	2026-02-10	English
INSIDE INFORMATION POTENTIAL DISPOSAL OF TIANMAI BIOTECHNOLOGY M&A Activity	2026-02-09	English
ARTICLES OF ASSOCIATION Governance Information	2026-02-06	English
POLL RESULTS OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING HELD ON 6 FEBRUARY 2026 Declaration of Voting Results & Voting Rights Announcements	2026-02-06	English
ANNOUNCEMENT PRELIMINARY FINANCIAL INFORMATION OF CR SANJIU FOR THE YEAR ENDED 31 DECEMBER 2025 Earnings Release FY 2025	2026-02-06	English
ANNOUNCEMENT PRINCIPAL OPERATING RESULTS ESTIMATE OF TASLY PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2025 Earnings Release FY 2025	2026-02-06	English
ANNOUNCEMENT PRELIMINARY FINANCIAL INFORMATION OF KPC FOR THE YEAR ENDED 31 DECEMBER 2025 Earnings Release FY 2025	2026-02-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-02	English
ANNOUNCEMENT RESULTS ESTIMATE OF CR BOYA BIO-PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2025 Earnings Release FY 2025	2026-01-30	English
INSIDE INFORMATION REGISTRATION OF CORPORATE BONDS BY THE CHINA SECURITIES REGULATORY COMMISSION Capital/Financing Update	2026-01-26	English
ANNOUNCEMENT PRINCIPAL OPERATING RESULTS ESTIMATE OF JIANGZHONG PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2025 Earnings Release FY 2025	2026-01-23	English
Documents on Display Regulatory Filings	2026-01-19	English
Notification of publication of corporate communications on the Company's website Report Publication Announcement	2026-01-19	English
Letter to new shareholders - election of means of receipt of corporate communications Legal Proceedings Report	2026-01-19	English
Letter to those shareholders who have elected to receive the corporate communications through the Company's website Report Publication Announcement	2026-01-19	English
Letter to those shareholders who have elected to receive the printed form of corporate communications Proxy Solicitation & Information Statement	2026-01-19	English
Proxy Form Proxy Solicitation & Information Statement	2026-01-19	English
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2026-01-19	English
CONTINUING CONNECTED TRANSACTIONS SALES FRAMEWORK AGREEMENT 2026/2028 ADOPTION OF THE NEW ARTICLES OF ASSOCIATION AND NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING AGM Information	2026-01-19	English
DELAY IN DESPATCH OF CIRCULAR Regulatory Filings	2026-01-15	English
DELAY IN DESPATCH OF CIRCULAR Regulatory Filings	2026-01-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Regulatory Filings	2026-01-02	English

Filings by year

2026 53 filings
2025 95 filings
2024 114 filings
2023 90 filings
2022 85 filings
2021 72 filings
2020 86 filings
2019 63 filings
2018 63 filings
2017 59 filings
2016 31 filings